Biblio Discovery — Demo Discovery Service

164 results for "Elliott, Perry"

Showing 1–20 · 1.00 seconds · RSS

  1. Journal Article Full text

    Foreword to the Special Issue: HCM in 2018

    Elliott, Perry

    Glob Cardiol Sci Pract · 2018 · English · PubMed Central

  2. Journal Article Full text

    Investigation and treatment of hypertrophic cardiomyopathy

    Elliott, Perry

    Clin Med (Lond) · 2007 · English · PubMed Central

  3. Journal Article Full text

    Towards a New Classification of Cardiomyopathies

    Elliott, Perry

    Curr Cardiol Rep · 2023 · English · PubMed Central

    PURPOSE OF REVIEW: The aim of this paper is to briefly summarise the clinical approach to disease notation for cardiomyopathies and to highlight its limitations with respect to the integration of new knowledge about aetiology. RECENT FINDINGS: The paper uses the recently advocated concept of…

  4. Journal Article Full text

    The genetics of hypertrophic cardiomyopathy

    Akhtar, Mohammed; Elliott, Perry

    Glob Cardiol Sci Pract · 2018 · English · PubMed Central

    Hypertrophic cardiomyopathy (HCM) is most commonly transmitted as an autosomal dominant trait, caused by mutations in genes encoding cardiac sarcomere proteins(1–3). Other inheritable causes of the disease include mutations in genes coding for proteins important in calcium handling or that form…

  5. Journal Article Full text

    Sudden death in athletes

    Patel, Vimal; Elliott, Perry

    Clin Med (Lond) · 2012 · English · PubMed Central

    Sudden cardiac death in an athlete is a rare and heartrending event, often occurring in the absence of warning symptoms. The causes of sudden cardiac death in athletes are age dependent and demonstrate a degree of geographical variation. Pre-participation screening is recommended by both the…

  6. Journal Article Full text

    Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?

    Protonotarios, Alexandros; Elliott, Perry M

    Eur Cardiol · 2020 · English · PubMed Central

    Arrhythmogenic cardiomyopathy (AC) is a clinical entity that has evolved conceptually over the past 30 years. Advances in cardiac imaging and the introduction of genetics into everyday practice have revealed that AC comprises multiple phenotypes that are dependent on genetic or acquired factors. In…

  7. Journal Article Full text

    Almanac 2011: Cardiomyopathies. the National Society Journals Present Selected Research That Has Driven Recent Advances in Clinical Cardiology

    M. Elliott, Perry; A. Mohiddin, Saidi

    Acta Inform Med · 2011 · English · PubMed Central

    As we approach the end of 2011 it is clear that the next few years are going to be dominated by the application of new high throughput genetic screening techniques, capable of screening the entire exome or indeed genome. Understanding the data generated by these techniques will require new and…

  8. Journal Article Full text

    Hidden in Heart Failure

    Cannie, Douglas Ewan; Akhtar, Mohammed Majid; Elliott, Perry

    Eur Cardiol · 2019 · English · PubMed Central

    Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction…

  9. Journal Article Full text

    Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta‐analysis

    Brownrigg, Jack; Lorenzini, Massimiliano; Lumley, Matthew et al.

    ESC Heart Fail · 2019 · English · PubMed Central

    AIMS: The study aims to systematically assess the diagnostic performance of cardiac magnetic resonance (CMR) and nuclear scintigraphy (index tests) for the diagnosis and differentiation of subtypes of cardiac amyloidosis. METHODS AND RESULTS: MEDLINE and Embase electronic databases were searched…

  10. Journal Article Full text

    The dilemma of an incidental preoperative electrocardiogram showing a Brugada phenotype

    Welman, Kiera; Matloob, Samir; Dubrey, Simon William et al.

    BMJ Case Rep · 2011 · English · PubMed Central

    A Brugada pattern on routine electrocardiography is one of several features that can indicate the potential for life threatening rhythm disturbances. The authors describe such a scenario in an asymptomatic 38-year-old woman who required significant surgery under anaesthesia. The diagnosis and…

  11. Journal Article Full text

    Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice

    Lopes, Luis R; Ho, Carolyn Y; Elliott, Perry M

    Eur Heart J · 2024 · English · PubMed Central

    Pathogenic variation in genes encoding proteins of the cardiac sarcomere is responsible for 30%–40% of cases of hypertrophic cardiomyopathy. The main clinical utility of genetic testing is to provide diagnostic confirmation and facilitation of family screening. It also assists in the detection of…

  12. Journal Article Full text

    Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

    Maurer, Mathew S.; Elliott, Perry; Comenzo, Raymond et al.

    Circulation · 2017 · English · PubMed Central

    Advances in cardiac imaging have resulted in greater recognition of cardiac amyloidosis (CA) in everyday clinical practice, but the diagnosis continues to be made in patients with late stage disease, suggesting that more needs to be done to improve awareness of its clinical manifestations and the…

  13. Journal Article Full text

    Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy

    Braunwald, Eugene; Saberi, Sara; Abraham, Theodore P et al.

    Eur Heart J · 2023 · English · PubMed Central

    Mavacamten is a first-in-class, targeted, cardiac-specific myosin inhibitor approved by the US Food and Drug Administration for the treatment of adults with symptomatic New York Heart Association Classes II and III obstructive hypertrophic cardiomyopathy (oHCM). Mavacamten was developed to target…

  14. Journal Article Full text

    Is QT Dispersion Associated with Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy?

    Yi, Gang; Poloniecki, Jan; Dickie, Shaughan et al.

    Ann Noninvasive Electrocardiol · 2006 · English · PubMed Central

    QT dispersion is significantly greater in patients with hypertrophic cardiomyopathy (HCM) than that in healthy subjects. Few data exist regarding the prognostic value of QT dispersion in HCM. In this study, we retrospectively investigated the association between QT dispersion and sudden cardiac…